Arun Patel, MD
Geriatric Medicine · Salamanca, NYNPI 1205815255
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 276 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among geriatric medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 276 payments — averaging $21.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$991
- AstraZeneca$870
- Novo Nordisk$595
- Lilly USA, LLC$435
- Johnson & Johnson$272
- Otsuka America Pharmaceutical, Inc.$257
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,823100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 39 | $991 |
| AstraZeneca | 31 | $870 |
| Novo Nordisk | 36 | $595 |
| Lilly USA, LLC | 24 | $435 |
| Johnson & Johnson | 16 | $272 |
| Otsuka America Pharmaceutical, Inc. | 13 | $257 |
| Merck | 16 | $257 |
| Boehringer Ingelheim | 9 | $254 |
| E.r. Squibb & Sons, L.L.C. | 7 | $210 |
| Lundbeck LLC | 6 | $166 |
| Neurocrine Biosciences, Inc. | 9 | $157 |
| Pfizer | 10 | $153 |
| Novartis | 5 | $139 |
| Amgen | 4 | $134 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $99 |
| Amarin Pharma, Inc. | 6 | $98 |
| Bayer | 5 | $93 |
| AbbVie | 3 | $59 |
| Nestle Healthcare Nutrition Inc. | 3 | $51 |
| Edwards Lifesciences | 2 | $49 |
| Sanofi-aventis U.S. LLC | 3 | $47 |
| Sunovion Pharmaceuticals Inc. | 3 | $44 |
| Mylan Specialty L.p. | 2 | $43 |
| Organogenesis Inc. | 1 | $39 |
| Boston Scientific | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Astellas Pharma US Inc | 2 | $33 |
| Grifols USA, LLC | 2 | $32 |
| Eisai Inc. | 1 | $20 |
| Gilead | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Almatica Pharma LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AREXVY$250
- BREZTRI$248
- TRELEGY ELLIPTA$230
- AIRSUPRA$125
- ELIQUIS$123
How this compares
$5,823 in reported general payments places this provider in the 90th percentile of 400 geriatric medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 83 | $205,804 |
| EliquisApixaban | 950 | $203,997 |
| JanuviaSitagliptin Phosphate | 405 | $82,682 |
| XareltoRivaroxaban | 315 | $59,863 |
| JardianceEmpagliflozin | 155 | $59,615 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $33,885 |
| MyrbetriqMirabegron | 160 | $25,768 |
| TrulicityDulaglutide | 17 | $24,617 |
| EntrestoSacubitril/Valsartan | 122 | $22,925 |
| OzempicSemaglutide | 11 | $21,271 |
| FarxigaDapagliflozin Propanediol | 61 | $20,432 |
| RexultiBrexpiprazole | 34 | $19,906 |
| NuedextaDextromethorphan Hbr/Quinidine | 37 | $19,009 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 34 | $11,162 |
| Breo ElliptaFluticasone/Vilanterol | 14 | $10,180 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo, Paxlovid | $153 | $219,5291,002 claims |
| MerckJanuvia | $257 | $82,682405 claims |
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $254 | $75,463216 claims |
| Johnson & JohnsonXarelto, Invokana | $272 | $67,817368 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta | $991 | $51,34678 claims |
| Astellas Pharma US IncMyrbetriq | $33 | $25,768160 claims |
| Lilly USA, LLCTrulicity | $435 | $24,61717 claims |
| NovartisEntresto | $139 | $22,925122 claims |
| Novo NordiskOzempic | $595 | $21,27111 claims |
| AstraZenecaFarxiga | $870 | $20,43261 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $257 | $19,90634 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $17 | $5,49536 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 400 geriatric medicine providers in New York.
Other geriatric medicine in Salamanca
- Wen DombrowskiBrooklyn$45K
- Sharon BrangmanSyracuse$45K
- Howard FillitNew York$42K
- Adam CohenGreat Neck$27K
- Inna ShifrinBrooklyn$21K
- Amit SaxenaBronx$16K
- Nirmala TummalapentaBronx$16K
- Nasem SayeghElmsford$15K
- Bruce LowellGreat Neck$14K
- Andre SerretteHewlett$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.